Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma

An estimated 98,000 patients with severe uncontrolled asthma may be eligible for the new treatment

- PMLiVE

Healthware Group report on depression care in Italy highlights need for digital therapeutics

Mental health disorders are the fifth leading cause of disability adjusted life years in Italy

- PMLiVE

Masking the truth

Why a not-so-good editorial piece from The New York Times has me a little vexed

The speed of science and the pace of comms

Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes.

Fox&Cat

- PMLiVE

MSD’s Keytruda to be made available in England for advanced cervical cancer patients

Around 2,600 people are diagnosed with cervical cancer each year in England

- PMLiVE

Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility

The biologics manufacturing site is expected to create more than 300 highly skilled jobs

- PMLiVE

Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies

The deal to develop a small-molecule inhibitor could be worth over $480m

regeneron headquarters

Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies

Sonoma will receive $75m upfront and will be eligible for a $45m milestone payment

- PMLiVE

Improving cardiovascular disease care and awareness

Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time

- PMLiVE

PMGroup announces launch of new recruitment platform PharmaRole

The platform makes it easy to find and apply for jobs in the pharmaceutical and life sciences industry

- PMLiVE

Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer

It is estimated there will be around 66,000 new cases of uterine cancer in the US this year

- PMLiVE

AstraZeneca’s mild combination asthma reliever approved in UK

Over two and a half million adults with mild cases of asthma could be eligible for the treatment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links